Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Arovella Therapeutics Ltd
ALACurrent price
0.21 AUD
0 AUD (0.00%)
Last closed
0.21 AUD
Company
–
ISIN
AU0000182784
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
204 553 574 AUD
Yield for 12 month
+122.83 %
1Y
3Y
5Y
10Y
15Y
ALA
Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally. The company product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia. Address: Corporate One, Preston, VIC, Australia, 3072
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.22 AUDP/E ratio
–Dividend Yield
–Current Year
+17 327 AUD
Last Year
+413 721 AUD
Current Quarter
+4 332 AUD
Last Quarter
+4 332 AUD
Current Year
-26 480 AUD
Last Year
-3 057 696 AUD
Current Quarter
-16 219 AUD
Last Quarter
+4 332 AUD
Key Figures ALA
1 year
3 years
5 years
10 years
EBITDA
-9 003 409 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-59.16 %
PEG Ratio
–
Return On Equity TTM
-116.55 %
Wall Street Target Price
0.22 AUD
Revenue TTM
1 989 747 AUD
Book Value
0.011 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-67.7 %
Dividend Yield
–
Gross Profit TTM
1 275 255 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
14.11.2019
Dividend Date
–
Stock Valuation ALA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
11600.6796
Price Sales TTM
105.5092
Enterprise Value EBITDA
-3.352
Price Book MRQ
17.8737
Financials ALA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALA
For 52 weeks
0.082 AUD
0.21 AUD
50 Day MA
0.17 AUD
Shares Short Prior Month
–
200 Day MA
0.15 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart